Analysis of Pyridostigmine Bromide in Human Plasma and its Application in Bioequivalence Studies

References

• Havel , J. , Patocka , J. and Bocaz , G. 2002 . Determination of physostigmine and pyridostigmine in pharmaceutical formulations by capillary electrophoresis . J. Cap. Elec. Microchip. Technol. , 7 : 107 – 112 .
   PubMedGoogle Scholar
• Fisher , D. M. 1999 . Clinical pharmacology of neuromuscular blocking agents . Am. J. Health Syst. Pharm. , 56 ( 11Suppl 1 ) : S4 – 9 .
   PubMed Web of Science ®Google Scholar
• Breyer‐Pfaff , U. , Maier , U. , Brinkmann , A. M. and Schumm , F. 1985 . Pyridostigmine kinetics in healthy subjects and patients with Myasthenia gravis . Clin. Pharmacol. Ther. , 37 : 495 – 501 .
   PubMed Web of Science ®Google Scholar
• Sapolsky , R. M. 1998 . The stress of gulf war syndrome . Nature , 393 : 308 – 309 .
   PubMed Web of Science ®Google Scholar
• Blick , D. W. , Murphy , M. R. , Brown , G. C. , Yochmowitz , M. G. , Fanton , J. W. and Hartgraves , S. L. 1994 . Acute behavioral toxicity of pyridostigmine or soman in primates . Toxicol. Appl. Pharmacol. , 126 : 311 – 318 .
   PubMed Web of Science ®Google Scholar
• Marino , M. T. , Schuster , B. G. , Brueckner , R. P. , Lin , E. , Kaminskis , A. and Lasseter , K. C. 1998 . Population pharmacokinetics and pharmacodynamics of pyridostigmine bromide for prophylaxis against nerve agents in humans . J. Clin. Pharmacol. , 38 : 227 – 235 .
   PubMed Web of Science ®Google Scholar
• Gordan , J. J. , Leadbeater , L. and Maidment , M. P. 1978 . The protection of animals against organophosphate poisoning by pre‐treatment with a carbamate . Toxicol. Appl. Pharmacol. , 52 : 71 – 92 .
   Google Scholar
• Cook , J. E. , Kolka , M. A. and Wenger , C. B. 1992 . Chronic pyridostigmine bromide administration: side effects among soldiers working in a desert environment . Mil. Med. , 157 : 250 – 254 .
   PubMed Web of Science ®Google Scholar
• Izraeli , S. , Avgar , D. , Almog , S. , Shochat , I. , Tochner , Z. and Tamir , A. 1990 . The effect of repeated doses of 30 mg pyridostigmine bromide on pilot performance in an A‐4 flight simulator . Aviat. Space Environ. Med. , 61 : 430 – 432 .
   PubMedGoogle Scholar
• Wenger , B. , Quigley , M. D. and Kolka , M. A. 1993 . Seven day pyridostigmine administration and thermoregulation during rest and exercise in dry heat . Aviat. Space. Environ. Med. , 64 : 905 – 911 .
   PubMedGoogle Scholar
• Aquilonius , S. M. and Hartvig , P. 1986 . Clinical pharmacokinetics of cholinesterase inhibitors . Clin. Pharmacokinetics , 11 : 236 – 249 .
   PubMed Web of Science ®Google Scholar
• Zhao , B. , Moochhala , S. M. , Lu , J. , Tan , D. and Lai , M. H. 2006 . Determination of pyridostigmine bromide and its metabolites in biological samples . J. Pharm. Pharm. Sci. , 9 ( 1 ) : 71 – 81 .
   PubMed Web of Science ®Google Scholar
• Abu‐Qare , A. W. and Abou‐Donia , M. B. 2001 . Chromatographic method for the determination of diazepam, pyridostigmine bromide, and their metabolites in rat plasma and urine . J. Chromatogr. B. Biomed. Sci. Appl. , 754 ( 2 ) : 503 – 509 .
   PubMedGoogle Scholar
• Yakatan , G. J. and Tien , J. Y. 1979 . Quantitation of pyridostigmine in plasma using high performance liquid chromatography . J. Chromatogr. , 164 : 399 – 403 .
   PubMed Web of Science ®Google Scholar
• Ellin , R. I. , Zvirblis , P. and Wilson , M. R. 1982 . Method for isolation and determination of pyridostigmine and metabolites in urine and blood . J. Chromatogr. , 228 : 235 – 244 .
   PubMed Web of Science ®Google Scholar
• Chan , K. , Williams , N. E. , Baty , J. D. and Calvey , T. N. 1976 . A quantitative gas‐liquid chromatographic method for the determination of neostigmine and pyridostigmine in human plasma . J. Chromatogr. , 120 : 349 – 358 .
   PubMed Web of Science ®Google Scholar
• Meyer , H. G. , Lukey , B. J. , Gepp , R. T. , Corpuz , R. P. and Lieske , C. N. 1998 . A radioimmunoassay for pyridostigmine . J. Pharmacol. Exp. Ther. , 247 : 432 – 438 .
   Google Scholar